GSK’s Nucala Phase III trial shows promise in treating chronic lung disease
September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical
September 6, 2024: UK pharmaceutical giant GSK (GSK.L) announced that its asthma medicine, Nucala (mepolizumab), has shown positive results in a late-stage clinical
HQ Team September 6, 2024: The National Medical Products Administration (NMPA) of China has suspended the import, sale, and use of Dr Reddy’s
Harvard Medical School scientists have designed an artificial intelligence model similar to ChatGPT that detects cancer or predicts a tumour’s genetic profile.
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030
The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in
A second phase of the polio vaccination will start today in war-raved Gaza after 187,000 children under the age of 10 got oral
Abbott Laboratories has initiated a clinical trial to evaluate the use of the company's deep brain stimulation system to manage treatment-resistant depression, a
Cholera cases rose 13% and deaths by 71% in 2023 compared to a year earlier as a shortage of oral vaccines continues and
Anti-depressant fluoxetine or Prozac from human residues of urine and faeces have been detected in fish in fresh waters of Australia, a pollutant that